Medical News Print

Timely Information about your Health (September 5, 2018)

By: Randy S. Gerber, Esq., Founder of Pacient.care

In response to your request, we will continue to provide timely and quick-read articles that are consumer focused and intended to educate you, entertain you and help you make smarter and more cost-effective decisions for you and your family.

Today's topics have an Elvis theme:

ARE YOU LONESOME TONIGHT: loneliness and social isolation

According to a recent study by the Kaiser Foundation 1 in 5 of us feel lonely or socially isolated.  And not surprisingly these feelings are harmful to our personal relationships and/or physical health.  A majority of this group are under 50 years old.  Contributing to their loneliness and isolation are financial problems, declining health and mental health issues.  Having a support system like family and people you can confide in can help you right the ship.

RETURN TO SENDER: Recalls of Interest  

1.  Children's Advil Suspension Bubble Gum Flavored (4 oz bottle). Recalled by FDA because dosage cup is marked in teaspoons and instructions are in millimeters.  

2.  Valsartran (widely used heart drug).  Recalled by FDA because one of its ingredients contain substance linked to cancer. 

3.  Nasal Mist and Baby Oral Gels.  Recalled by manufacturer which includes all nasal products and baby oral gels made in Holly Hills Florida.

DOUBLE TROUBLE: post-partum depression with twins

Women giving birth to multiple children are more likely (43%) to experience post-partum depression during the first 3 months after delivery according to a recent study.   Despite the benefits of certain types of counseling few women seek help.  Finding child care and cost are two of the primary barriers.  On the plus side, grandparents can be a positive solution.

WITCHCRAFT: a pill that has a sensor

Coming to a pharmacy near year you (eventually) is a digital pill that contains a sensor to let your caregiver or doctor know that you've swallowed the pill.  The digital pill is currently being offered to Medicaid patients in the Florida and Virginia regions to treat schizophrenia and bipolar disorder.  The price tag of $1,650. 

If you need further information, feel free to email me with any questions or comments.  Randy.  rgerber@pacient.care